Company Profile
Sensei Biotherapeutics Stock Price, News & Analysis
- Ticker:
- SNSE
- Exchange:
- NYSE
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NYSE, Sensei Biotherapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
13.85 USD (+6.54%)
Close
Last updated: June 15, 2026 at 00:00
18.59M USD
Market cap
Why the stock is moving
SNSE is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Sensei Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Sensei Biotherapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Sensei Biotherapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Sensei Biotherapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Source: Sensei Biotherapeutics
- 03
- 04
- 05
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value
Source: Sensei Biotherapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Sensei Biotherapeutics (SNSE)?
Sensei Biotherapeutics (SNSE) most recently closed at 13.85 USD, a +6.54% move versus the previous session.
What is the market cap of Sensei Biotherapeutics (SNSE)?
Sensei Biotherapeutics currently has a market capitalization of 18.59M USD on BioPharmSignal.
What does Sensei Biotherapeutics do?
Sensei Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is SNSE stock listed?
Sensei Biotherapeutics (SNSE) is associated with NYSE, Headquartered in the United States and listed on NYSE, Sensei Biotherapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Sensei?
Sensei Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Sensei Biotherapeutics targeting with Sensei?
Sensei Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biotherapeutics?
Sensei Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.